Brief: Elevation Oncology Q3 basic EPS USD -0.25
02/11/2023 11:36
Nov 2 (Reuters) - Elevation Oncology Q3 pretax profit USD -10.625 million. * Q3 basic EPS USD -0.25 * Q3 net income USD -10.636 million * Q3 operating expenses USD 10.92 million * Q3 income from operations USD -10.92 million
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing